Home / Research / Product codes / QJR Medical-device intelligence
QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid FDA product code QJR: Reagents, 2019-Novel Coronavirus Nucleic Acid. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code QJR
FDA device name Reagents, 2019-Novel Coronavirus Nucleic Acid
Device class N
Regulation number Not provided
Medical specialty Unknown
Review panel MI FDA definition Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens. Explore unknown records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 0 clearance records and 40 recall records in the covered releases, across 16 source company names and 1 product codes. Dated history runs from Jul 20, 2020 to Apr 28, 2025.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 40 matching records Device / record Company in FDA record Source Source date OPTI SARS-CoV-2 RT-PCR Test, REF Numbers:
a) 99-57003
b) 99-57004 Z-2310-2021 · QJROPTI Medical Systems, Inc Recall Aug 17, 2021FDA record creation date NeuMoDx Cartridge, For In Vitro Diagnostic Use on the NeuMoDx 288 and NeuMoDx 96 Molecular Systems, Model Number 100100 Z-1978-2021 · QJRNeuMoDx Molecular Inc Recall Jun 29, 2021FDA record creation date Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent Z-1928-2021 · QJRQuidel Corporation Recall Jun 26, 2021FDA classification date Revogene SARS-CoV-2
Catalog Number: 410700
IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on … Z-1540-2021 · QJRMeridian Bioscience Inc Recall May 7, 2021FDA record creation date Revogene RNA Software Upgrade Kit
Revogene RNA Software Upgrade USBs
Catalog Number: 610240
IVD used to install the Revogene System Software ver… Z-1541-2021 · QJRMeridian Bioscience Inc Recall May 7, 2021FDA record creation date cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas Liat System,
Catalog Numbe… Z-1413-2021 · QJRRoche Molecular Systems, Inc. Recall Apr 13, 2021FDA record creation date cobas Liat Analyzer: respiratory virus panel nucleic acid assay system
Catalog Number: 07341920190 Z-1414-2021 · QJRRoche Molecular Systems, Inc. Recall Apr 13, 2021FDA record creation date BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasophary… Z-1416-2021 · QJRBecton Dickinson & Co. Recall Apr 13, 2021FDA record creation date BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic.
SARS-CoV-2 Reagents is a real-time RT-PCR test… Z-0954-2021 · QJRBecton Dickinson & Co. Recall Feb 5, 2021FDA record creation date Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in… Z-0940-2021 · QJRBiomeme, Inc. Recall Feb 1, 2021FDA record creation date visby medical COVID-19 Test kit *** An in vitro diagnostic for the qualitative detection of SARS-CoV-2 - Product Usage: The Visby Medical COVID-1… Z-0847-2021 · QJRVISBY MEDICAL INC Recall Jan 12, 2021FDA record creation date The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is a molecular in vitro diagnostic test that is based on widely used nucleic acid amplification tech… Z-0513-2021 · QJRBiomeme, Inc. Recall Dec 1, 2020FDA record creation date The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v1.2 for 7500 RTPCR instruments, includes the assays and … Z-2978-2020 · QJRLife Technologies Corporation Recall Sep 17, 2020FDA record creation date The TaqPath RT-PCR COVID-19 Kit with Applied Biosystem's COVID-19 Interpretive Software v2.0 or v2.2 (used with the QuantStudio Real-Time PCR pla… Z-2979-2020 · QJRLife Technologies Corporation Recall Sep 17, 2020FDA record creation date BD MAX SARS-CoV-2 Reagents, Cat. No. 445003 (UDI 00382904450038) and 445003-01 (UDI (01)603829044500301) - Product Usage: intended for the qualit… Z-2754-2020 · QJRBecton Dickinson & Co. Recall Aug 4, 2020FDA record creation date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗